Cancer, Chemotherapy Effect, Quality of Life, Self Efficacy
Conditions
Brief summary
The study will design and evaluate the use of mobile-health based self-management on self-efficacy and quality of life of patients undergoing chemotherapy.
Detailed description
The study will design and evaluate the use of mobile-health based self-management on self-efficacy and quality of life of patients undergoing chemotherapy.
Interventions
BEHAVIORALMobile-health self management
Mobile-health self management
Sponsors
Universitas Muhammadiyah Yogyakarta
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* adult patients diagnosed with cancer * patients who use smart phone
Exclusion criteria
* patients with cancer with comorbidity
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patient's Quality of life | Four weeks | The patient's quality of life will be assessed before (T0) and after intervention (T1). The measurement will use EORTC. The score will range from 0-100, where higher score reflects a better quality of life. |
| Patient's Self-efficacy | four weeks | The patients self-efficacy will be measured pre and post intervention. The measurement will use the Self-Efficacy for Managing Chronic Disease Scale. The scale has been widely used in cancer setting. Respondents will rate their confidence to perform six self-management behaviours (1 = 'not at all confident' to 10 = 'totally confident'). A mean score is calculated (range 1 to 10). A high score indicates high self-efficacy. |
Outcome results
None listed